Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Teicoplanin

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44344   clinical trials with a EudraCT protocol, of which   7373   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    21 result(s) found for: Teicoplanin. Displaying page 1 of 2.
    1  2  Next»
    EudraCT Number: 2005-000071-18 Sponsor Protocol Number: Teico HF Start Date*: 2005-04-26
    Sponsor Name:Medical University, Dpt. Internal Medicin, Division of General Inteal Medicine
    Full Title: Pharmakokinetik von Teicoplanin bei kritisch Kranken während kontinuierlicher veno-venöser Hämofiltration und während Albumindialyse (Pharmacokinetics of teicoplanin in critically ill durining ven...
    Medical condition: Plasma concentrations of teicoplanin will be measured in critically ill patients requirirng teicoplanin treatment for severe infection (proven or suspected infection with methicillin-resistant stap...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2013-004535-72 Sponsor Protocol Number: TEIC_HM_1 Start Date*: 2014-01-17
    Sponsor Name:Tallaght Hospital, Dublin 24, Ireland
    Full Title: A prospective, single-centre, cohort study to determine the pharmacokinetic and pharmacodynamic parameters of teicoplanin in adult patients with haematological malignancy.
    Medical condition: Suspected or confirmed Gram-positive infection in patients with haematological malignancy.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2012-005738-12 Sponsor Protocol Number: LIPSTIC.V.01 Start Date*: 2013-03-27
    Sponsor Name:Alder Hey Children's NHS Foundation Trust
    Full Title: Liverpool Pharmacokinetic/pharmacodynamics study of teicoplanin in children (LIPSTIC).
    Medical condition: Gram-positive bacterial infection: late-onset neonatal sepsis, central line-associated blood stream infection, ventilator-associated pneumonia.
    Disease:
    Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2020-000508-13 Sponsor Protocol Number: 72779 Start Date*: 2020-10-27
    Sponsor Name:Princess Máxima Center for Pediatric Oncology
    Full Title: An open-label, randomized clinical trial on teicoplanin infection prophylaxis in pediatric patients with acute myeloid leukemia
    Medical condition: Acute myeloid leukemia
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004864 10024346 Leukemia myeloblastic acute LLT
    Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: NL (Trial now transitioned) BE (Trial now transitioned) DK (Trial now transitioned) ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2023-000005-12 Sponsor Protocol Number: CRCFC-TEICO.SA.2022 Start Date*: 2024-02-21
    Sponsor Name:AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA
    Full Title: An open-label study to evaluate the safety and tolerability of inhaled Teicoplanin in the treatment of Staphylococcus aureus (including mrsa) infections in CYSTIC FIBROSIS PATIENTS
    Medical condition: cystic fibrosis associated to persistent Staphylococcus aureus (including MRSA) infection
    Disease: Version SOC Term Classification Code Term Level
    20.0 10010331 - Congenital, familial and genetic disorders 10011762 Cystic fibrosis PT
    20.0 100000004862 10075981 Staphylococcus aureus infection LLT
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: IT (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2009-011342-26 Sponsor Protocol Number: 06/09 Start Date*: 2009-11-12
    Sponsor Name:Great Western Hospital, Swindon
    Full Title: The use of prophylactic antibiotics for percutaneous K-wires in orthopaedic surgery
    Medical condition: INfection following k-wire insertion
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-001349-40 Sponsor Protocol Number: DAP002 Start Date*: 2005-07-31
    Sponsor Name:Novartis Pharma Services AG
    Full Title: A Multicentre, Randomised, Assessor-Blind Study to Evaluate Efficacy and Safety of Daptomycin versus Vancomycin or Teicoplanin for Treatment of Complicated Skin and Soft Tissue Infections (cSSTI)
    Medical condition: Complicated Skin and Soft Tissue Infections (cSSTI)
    Disease: Version SOC Term Classification Code Term Level
    8.1 10040786 Skin structures and soft tissue infections HLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended) ES (Completed) DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2009-015800-25 Sponsor Protocol Number: 810 Start Date*: 2010-01-19
    Sponsor Name:The Liverpool Heart & Chest Hospital NHS Trust
    Full Title: A pilot randomised control trial, in intensive care patients, comparing seven days versus two days treatment with empirical antibiotics to treat hospital acquired infection of unknown origin
    Medical condition: Healthcare associated infections This includes infections of the: • Skin and underneath the skin, including muscle - sometimes called ‘soft tissue’ • Urinary tract - including your kidneys or bladd...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2014-004628-23 Sponsor Protocol Number: M000507_6004 Start Date*: 2015-03-17
    Sponsor Name:Sanofi
    Full Title: Comparison of Teicoplanin and Vancomycin in Terms of Efficacy and Side Effect Profile During Initial Antibiotic Treatment of Febrile Neutropenic Patients at High Risk For Gram-Positive Infection: M...
    Medical condition: Neutropenic and febrile patients with hematological or solid tumors, who are at high risk for gram-positive bacterial infection.
    Disease: Version SOC Term Classification Code Term Level
    17.1 10021881 - Infections and infestations 10060945 Bacterial infection PT
    Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2006-005453-30 Sponsor Protocol Number: DAP-OST-06-02 Start Date*: 2007-09-11
    Sponsor Name:Cubist Pharmaceuticals, Inc.
    Full Title: A Phase 2 Randomized Study Investigating the Safety, Efficacy and Pharmacokinetics of Daptomycin 6 mg/kg and 8 mg/kg Versus Comparator in the Treatment of Subjects Undergoing Surgical Standard of ...
    Medical condition: Treatment of subjects undergoing surgical standard of care for osteomyelitis associated with an infected prosthetic hip or knee joint caused by methicillin-resistant Staphylococcus Aureus and/or co...
    Disease: Version SOC Term Classification Code Term Level
    9.1 10064250 Staphylococcal osteomyelitis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2009-016532-12 Sponsor Protocol Number: Version1.0 Start Date*: 2009-12-28
    Sponsor Name:Medical University of Vienna
    Full Title: Target tissue concentration of standard antibiotic treatment in coronary artery bypass grafting using left internal mammary artery
    Medical condition: antibiotic target tissue protection during cardiac surgery with the use of an internal mammary artery graft to prevent deep sternal wound infection
    Disease: Version SOC Term Classification Code Term Level
    12.0 10011078 Coronary artery disease LLT
    12.0 10036894 Prophylactic antibiotic therapy LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2010-022518-16 Sponsor Protocol Number: KADFUT Start Date*: 2011-07-13
    Sponsor Name:King's College Hospital NHS Foundation Trust
    Full Title: A prospective single blind randomised controlled study to compare the outcomes of patients with diabetes and clinically non-infected ischaemic and neuropathic foot ulcers treated with and without ...
    Medical condition: foot ulcers with no clinical signs of infection in patients with diabetes.
    Disease: Version SOC Term Classification Code Term Level
    14.0 10027433 - Metabolism and nutrition disorders 10012601 Diabetes mellitus PT
    14.0 10027433 - Metabolism and nutrition disorders 10012664 Diabetic foot ulcer LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2021-003914-38 Sponsor Protocol Number: 2021-003914-38 Start Date*: 2022-02-14
    Sponsor Name:Fundación Pública Andaluza para la Gestión de la Investigación
    Full Title: Efficacy and safety of different antimicrobial DURATions for the treatment of infections associated with Osteosynthesis Material implanted after long bone fractures (DURATIOM). Phase 4 pragmatic mu...
    Medical condition: Patients with long bone fractures who have had osteosynthesis material implanted to stabilize and assist fracture healing and meet the criteria for Infections associated with osteosynthesis material
    Disease: Version SOC Term Classification Code Term Level
    20.0 10021881 - Infections and infestations 10021881 Infections and infestations SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2013-000864-28 Sponsor Protocol Number: DAP-PEDOST-11-03 Start Date*: 2014-01-02
    Sponsor Name:Cubist Pharmaceuticals, LLC
    Full Title: A Multicenter, Randomized, Double-Blinded Comparative Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Daptomycin Versus Active Comparator in Pediatric Subjects With Acute Hematogeno...
    Medical condition: Acute Hematogenous Osteomyelitis Due to Gram-Positive Organisms
    Disease: Version SOC Term Classification Code Term Level
    19.1 100000004862 10009081 Chronic osteomyelitis LLT
    19.1 100000004862 10046076 Unspecified osteomyelitis LLT
    19.1 100000004862 10009091 Chronic osteomyelitis, site unspecified LLT
    Population Age: Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: DE (Completed) HU (Completed) IT (Completed) ES (Completed) GR (Completed) LV (Completed) GB (Completed) EE (Completed) BG (Completed) FR (Completed) SI (Completed) Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2012-003146-32 Sponsor Protocol Number: ASSIT Start Date*: 2013-03-04
    Sponsor Name:Hull and East Yorkshire Hospital Trust
    Full Title: A randomised control trial to determine whether a 5 day course of antibiotics is more clinically and cost effective than a 24 hour prophylactic course for the prevention of surgical site infection ...
    Medical condition: Incidence of Surgical Site infection following major lower limb amputation surgery
    Disease: Version SOC Term Classification Code Term Level
    14.1 10021881 - Infections and infestations 10036410 Postoperative wound infection PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2010-021242-22 Sponsor Protocol Number: PHRN09-LB / DATIPO Start Date*: 2011-07-26
    Sponsor Name:CHRU de Tours
    Full Title: Etude multicentrique, de non infériorité, randomisée, ouverte, évaluant l’efficacité de deux Durées d’Antibiothérapie (6 semaines versus 12 semaines) dans le Traitement des Infections sur Prothèses...
    Medical condition: Infection sur prothèse ostéo-articulaire
    Disease: Version SOC Term Classification Code Term Level
    13.1 10061017 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2008-008013-19 Sponsor Protocol Number: MAMA2009 Start Date*: 2009-05-21
    Sponsor Name:Joan Xavier Fontdevila Font
    Full Title: Estudio aleatorizado para determinar la utilidad de la teicoplanina en la reducción de la colonización bacteriana de la superficie del expansor mamario en cirugía reconstructiva de mama
    Medical condition: Disminución de la colonización bacteriana en la cirugía reconstructiva de mama con la técnica en 2 tiempos (expansor-prótesis)
    Disease: Version SOC Term Classification Code Term Level
    9 10006188 Breast cancer female NOS LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-023814-29 Sponsor Protocol Number: CAS110775 Start Date*: 2011-06-17
    Sponsor Name:Instituto Científico y Tecnológico de Navarra
    Full Title: Concentración y actividad antibiótica en soluciones de sellado
    Medical condition: Pacientes con catéter venoso central con reservorio subcutáneo
    Disease: Version SOC Term Classification Code Term Level
    13 10053377 Cateterización venosa central PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2011-003176-36 Sponsor Protocol Number: Duration Start Date*: 2011-12-20
    Sponsor Name:FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO DI MILANO
    Full Title: Individualizing duration of antibiotic therapy in hospitalized patients with community-acquired pneumonia: a non-inferiority, randomized, controlled trial.
    Medical condition: Subjects with diagnosis of pneumonia
    Disease: Version SOC Term Classification Code Term Level
    14.1 10021881 - Infections and infestations 10035739 Pneumonia, organism unspecified LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2015-000203-89 Sponsor Protocol Number: NeoVanc Start Date*: 2016-07-18
    Sponsor Name:Fondazione PENTA Onlus
    Full Title: Multi-centre, randomised, open label, phase IIb study to compare the efficacy, safety and pharmacokinetics (PK) of an optimised dosing to a standard dosing regimen of vancomycin in neonates and inf...
    Medical condition: Neonatal late onset sepsis
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004862 10053598 Late onset neonatal sepsis LLT
    Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 Gender: Male, Female
    Trial protocol: GB (Prematurely Ended) IT (Prematurely Ended) EE (Prematurely Ended) ES (Prematurely Ended) GR (Prematurely Ended)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Wed Jun 18 00:20:51 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA